首页> 外国专利> Crystal form of dabigatran etexilate mesylate and preparation method and use thereof

Crystal form of dabigatran etexilate mesylate and preparation method and use thereof

机译:达比加群酯甲磺酸盐的晶型及其制备方法和用途

摘要

The present invention relates to novel crystal forms M and N of dabigatran etexilate mesylate and preparation method and uses thereof, wherein the X-Ray powder diffractogram of the crystal form M has characteristic peaks at the following 2θ diffraction angles: 5.7±0.2°, 6.2±0.2°, 11.2±0.2°, 12.4±0.2°, 18.2±0.2°, 21.4±0.2°, 21.8±0.2° and 23.6±0.2°; and the X-Ray powder diffractogram of the crystal form N has characteristic peaks at the following 2θ diffraction angles: 6.0±0.2°, 11.8±0.2°, 18.2±0.2°, 21.6±0.2°, 24.4±0.2°, 27.7±0.2° and 29.7±0.2°. The crystal forms of the present invention have excellent properties in the aspects of leaching time, biological release, chemical stability and processing adaptability.
机译:本发明涉及达比加群酯甲磺酸盐的新型晶型M和N及其制备方法和用途,其中晶型M的X射线粉末衍射图在以下2θ衍射角上具有特征峰:5.7±0.2°,6.2 ±0.2°,11.2±0.2°,12.4±0.2°,18.2±0.2°,21.4±0.2°,21.8±0.2°和23.6±0.2°;晶型N的X射线粉末衍射图在以下2θ衍射角处具有特征峰:6.0±0.2°,11.8±0.2°,18.2±0.2°,21.6±0.2°,24.4±0.2°,27.7±0.2 °和29.7±0.2°。本发明的晶型在浸出时间,生物释放,化学稳定性和加工适应性方面具有优异的性能。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号